2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      EPR Studies of Aβ42 Oligomers Indicate a Parallel In-Register β-Sheet Structure

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aβ aggregation leads to the formation of both insoluble amyloid fibrils and soluble oligomers. Understanding the structures of Aβ oligomers is important for delineating the mechanism of Aβ aggregation and developing effective therapeutics. Here, we use site-directed spin labeling and electron paramagnetic resonance (EPR) spectroscopy to study Aβ42 oligomers prepared by using the protocol of Aβ-derived diffusible ligands. We obtained the EPR spectra of 37 Aβ42 oligomer samples, each spin-labeled at a unique residue position of the Aβ42 sequence. Analysis of the disordered EPR components shows that the N-terminal region has a lower local structural stability. Spin label mobility analysis reveals three structured segments at residues 9–11, 15–22, and 30–40. Intermolecular spin–spin interactions indicate a parallel in-register β-sheet structure, with residues 34–38 forming the structural core. Residues 16–21 also adopt the parallel in-register β-structure, albeit with weaker intermolecular packing. Our results suggest that there is a structural class of Aβ oligomers that adopt fibril-like conformations.

          Related collections

          Most cited references71

          • Record: found
          • Abstract: found
          • Article: not found

          Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

          Soluble oligomers are common to most amyloids and may represent the primary toxic species of amyloids, like the Abeta peptide in Alzheimer's disease (AD). Here we show that all of the soluble oligomers tested display a common conformation-dependent structure that is unique to soluble oligomers regardless of sequence. The in vitro toxicity of soluble oligomers is inhibited by oligomer-specific antibody. Soluble oligomers have a unique distribution in human AD brain that is distinct from fibrillar amyloid. These results indicate that different types of soluble amyloid oligomers have a common structure and suggest they share a common mechanism of toxicity.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Alzheimer disease

            Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing plaques and tau-containing neurofibrillary tangles. AD is a genetic and sporadic neurodegenerative disease that causes an amnestic cognitive impairment in its prototypical presentation and non-amnestic cognitive impairment in its less common variants. AD is a common cause of cognitive impairment acquired in midlife and late-life but its clinical impact is modified by other neurodegenerative and cerebrovascular conditions. This Primer conceives of AD biology as the brain disorder that results from a complex interplay of loss of synaptic homeostasis and dysfunction in the highly interrelated endosomal/lysosomal clearance pathways in which the precursors, aggregated species and post-translationally modified products of Aβ and tau play important roles. Therapeutic endeavours are still struggling to find targets within this framework that substantially change the clinical course in persons with AD.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils

              The Aβ42 peptide rapidly aggregates to form oligomers, protofibils and fibrils en route to the deposition of amyloid plaques associated with Alzheimer's disease. We show that low temperature and low salt can stabilize disc-shaped oligomers (pentamers) that are significantly more toxic to murine cortical neurons than protofibrils and fibrils. We find that these neurotoxic oligomers do not have the β-sheet structure characteristic of fibrils. Rather, the oligomers are composed of loosely aggregated strands whose C-terminus is protected from solvent exchange and which have a turn conformation placing Phe19 in contact with Leu34. On the basis of NMR spectroscopy, we show that the structural conversion of Aβ42 oligomers to fibrils involves the association of these loosely aggregated strands into β-sheets whose individual β-strands polymerize in a parallel, in-register orientation and are staggered at an inter-monomer contact between Gln15 and Gly37.
                Bookmark

                Author and article information

                Journal
                ACS Chem Neurosci
                ACS Chem Neurosci
                cn
                acncdm
                ACS Chemical Neuroscience
                American Chemical Society
                1948-7193
                18 December 2023
                03 January 2024
                : 15
                : 1
                : 86-97
                Affiliations
                [1]Department of Neurology, Brain Research Institute, David Geffen School of Medicine, University of California, Los Angeles , Los Angeles, California 90095, United States
                Author notes
                Author information
                https://orcid.org/0009-0007-8737-9162
                https://orcid.org/0000-0003-1992-7255
                Article
                10.1021/acschemneuro.3c00364
                10767747
                38109787
                0ef04b33-4af1-4b35-b081-ab664d9b8f0e
                © 2023 The Authors. Published by American Chemical Society

                Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained ( https://creativecommons.org/licenses/by/4.0/).

                History
                : 25 May 2023
                : 30 November 2023
                : 31 October 2023
                Funding
                Funded by: National Institute on Aging, doi 10.13039/100000049;
                Award ID: R01AG050687
                Categories
                Research Article
                Custom metadata
                cn3c00364
                cn3c00364

                Neurosciences
                alzheimer’s disease,protein aggregation,electron paramagnetic resonance,amyloid,addls,oligomers

                Comments

                Comment on this article